$32.74
4.53% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US8292141053
Symbol
SLP

Simulations Plus, Inc. Stock price

$32.74
+2.06 6.71% 1M
-17.09 34.30% 6M
-12.01 26.84% YTD
-6.65 16.88% 1Y
-18.30 35.85% 3Y
-1.93 5.57% 5Y
+26.26 405.25% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+1.42 4.53%
ISIN
US8292141053
Symbol
SLP

Key metrics

Market capitalization $657.00m
Enterprise Value $637.75m
P/E (TTM) P/E ratio 66.84
EV/FCF (TTM) EV/FCF 50.02
EV/Sales (TTM) EV/Sales 9.11
P/S ratio (TTM) P/S ratio 9.38
P/B ratio (TTM) P/B ratio 3.60
Dividend yield 0.73%
Last dividend (FY24) $0.24
Revenue growth (TTM) Revenue growth 17.52%
Revenue (TTM) Revenue $70.01m
EBIT (operating result TTM) EBIT $6.13m
Free Cash Flow (TTM) Free Cash Flow $12.75m
Cash position $20.26m
EPS (TTM) EPS $0.49
P/E forward 45.16
P/S forward 7.24
EV/Sales forward 7.03
Short interest 8.74%
Show more

Is Simulations Plus, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Simulations Plus, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Simulations Plus, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Simulations Plus, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Simulations Plus, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
70 70
18% 18%
100%
- Direct Costs 27 27
131% 131%
38%
43 43
10% 10%
62%
- Selling and Administrative Expenses 26 26
16% 16%
37%
- Research and Development Expense 5.75 5.75
28% 28%
8%
12 12
9% 9%
17%
- Depreciation and Amortization 5.67 5.67
48% 48%
8%
EBIT (Operating Income) EBIT 6.13 6.13
33% 33%
9%
Net Profit 9.95 9.95
0% 0%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Simulations Plus, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Simulations Plus, Inc. Stock News

Neutral
Business Wire
7 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--CEO of Simulations Plus, Shawn O'Connor, will participate in a panel discussion at the virtual BTIG Digital Health Forum on Monday, November 25, 2024.
Neutral
Business Wire
13 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, in partnership with the University of Connecticut, was awarded a new FDA grant to investigate additional LAI product technologies.
Neutral
Business Wire
20 days ago
LANCASTER, Calif.--(BUSINESS WIRE)--Shawn O'Connor, CEO, will participate in a fireside chat at the Stephens Annual Investment Conference on Wednesday, November 20, 2024 at 12:00pm ET.
More Simulations Plus, Inc. News

Company Profile

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Head office United States
CEO Shawn O'Connor
Employees 247
Founded 1996
Website www.simulations-plus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today